
Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review
Description
Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Sartorius AG (Sartorius) is a medical device company that offers laboratory and process technology equipment. The company's product portfolio includes cell lines; cell culture media; reagents; bioreactors; technologies for the separation, purification, and concentration of biological intermediates and end products; solutions for storage and transportation; laboratory balances; pipettes; lab water systems; and consumables, such as filters and microbiological test kits; among others. It also offers services such as bioprocess consulting and engineering, cell culture media services, biologics testing, instrument service, and validation services. Sartorius serves pharmaceutical and biotechnology companies, academic research facilities, and quality control labs in the chemical and food industries. The company's products are used in applications such as drug development, biopharmaceutical manufacturing, and quality control. Sartorius is headquartered in Gottingen, Niedersachsen, Germany.
Sartorius AG Key Recent Developments
Jun 24,2025: Kicking Off, Process Intensified. Drug Manufacturing Accelerated. The Sartorius PI Forum opens in Boston -- shaping biomanufacturing's future
Jun 17,2025: Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France
May 02,2025: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
Apr 16,2025: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter Read Media Release
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Sartorius AG (Sartorius) is a medical device company that offers laboratory and process technology equipment. The company's product portfolio includes cell lines; cell culture media; reagents; bioreactors; technologies for the separation, purification, and concentration of biological intermediates and end products; solutions for storage and transportation; laboratory balances; pipettes; lab water systems; and consumables, such as filters and microbiological test kits; among others. It also offers services such as bioprocess consulting and engineering, cell culture media services, biologics testing, instrument service, and validation services. Sartorius serves pharmaceutical and biotechnology companies, academic research facilities, and quality control labs in the chemical and food industries. The company's products are used in applications such as drug development, biopharmaceutical manufacturing, and quality control. Sartorius is headquartered in Gottingen, Niedersachsen, Germany.
Sartorius AG Key Recent Developments
Jun 24,2025: Kicking Off, Process Intensified. Drug Manufacturing Accelerated. The Sartorius PI Forum opens in Boston -- shaping biomanufacturing's future
Jun 17,2025: Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France
May 02,2025: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
Apr 16,2025: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter Read Media Release
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
62 Pages
- Section 1 - About the Company
- Sartorius AG - Key Facts
- Sartorius AG - Key Employees
- Sartorius AG - Key Employee Biographies
- Sartorius AG - Major Products and Services
- Sartorius AG - History
- Sartorius AG - Company Statement
- Sartorius AG - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Sartorius AG - Business Description
- Business Segment: Bioprocess Solutions
- Overview
- Performance
- Key Stats
- Business Segment: Lab Products & Services
- Overview
- Performance
- Key Stats
- Geographical Segment: Americas (Excluding USA)
- Performance
- Geographical Segment: Asia Pacific (Excluding China, South Korea)
- Performance
- Geographical Segment: China
- Performance
- Geographical Segment: EMEA (Excluding Germany, France)
- Performance
- Geographical Segment: France
- Performance
- Geographical Segment: Germany
- Performance
- Geographical Segment: South Korea
- Performance
- Geographical Segment: USA
- Performance
- R&D Overview
- Sartorius AG - Corporate Strategy
- Sartorius AG - SWOT Analysis
- SWOT Analysis - Overview
- Sartorius AG - Strengths
- Sartorius AG - Weaknesses
- Sartorius AG - Opportunities
- Sartorius AG - Threats
- Sartorius AG - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Sartorius AG, Medical Equipment, Deals By Year, 2019 to YTD 2025
- Sartorius AG, Medical Equipment, Deals By Type, 2019 to YTD 2025
- Sartorius AG, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Jun 24, 2025: Kicking Off, Process Intensified. Drug Manufacturing Accelerated. The Sartorius PI Forum opens in Boston -- shaping biomanufacturing's future
- Jun 17, 2025: Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France
- May 02, 2025: Sartorius Supervisory Board extends appointment of board member Alexandra Gatzemeyer
- Apr 16, 2025: Strong start to the year: Sartorius achieves significant profitable growth in the first quarter Read Media Release
- Mar 07, 2025: Mycenax and Sartorius Join Forces to Enhance Biopharmaceutical Manufacturing Solutions
- Jan 28, 2025: Sartorius Closes Fiscal 2024 With Very Good Fourth Quarter and Positive Trend; Full-Year Guidance Achieved
- Jan 22, 2025: Extended Collaboration With Sartorius Powers New Biomanufacturing Lab at McMaster University, Canada
- Jul 18, 2024: Half-Year Results: Moderately Positive Revenue Development in the Second Quarter; Demand Recovery Remains Muted, Full-Year Outlook Deliberately More Cautious; Long-Term Trends Remain Positive
- Jun 05, 2024: Sartorius Opens New Center of Excellence for Bioanalytics in Ann Arbor
- Apr 18, 2024: Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Sartorius AG, Key Facts
- Sartorius AG, Key Employees
- Sartorius AG, Key Employee Biographies
- Sartorius AG, Major Products and Services
- Sartorius AG, History
- Sartorius AG, Other Locations
- Sartorius AG, Subsidiaries
- Sartorius AG, Key Competitors
- Sartorius AG, Ratios based on current share price
- Sartorius AG, Annual Ratios
- Sartorius AG, Annual Ratios (Cont...1)
- Sartorius AG, Annual Ratios (Cont...2)
- Sartorius AG, Interim Ratios
- Sartorius AG, Medical Equipment, Deals By Year, 2019 to YTD 2025
- Sartorius AG, Medical Equipment, Deals By Type, 2019 to YTD 2025
- Sartorius AG, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Sartorius AG, Performance Chart (2020 - 2024)
- Sartorius AG, Ratio Charts
- Sartorius AG, Medical Equipment, Deals By Year, 2019 to YTD 2025
- Sartorius AG, Medical Equipment, Deals by Type, 2019 to YTD 2025
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.